Skip to main content
. 2018 Aug 20;9:1949. doi: 10.3389/fmicb.2018.01949

Table 1.

Drug resistance characteristics of Pseudomonas aeruginosa clinical isolates used in the study.

Strain Source of isolation PIP TIM TZP FEP CAZ IPM MEM DOR GEN AMK NET TOB CIP LVX CST PMB FOF AZT Resistance status
1 10145 ND R
2 3042/s Urine R R
3 3318/p Ear R
4 2969/s Wound
5 1561/o Bronchi R R R R R R MDR
6 3404/p Urine R R
7 3117/s Abdomen R
8 3146/s Wound R
9 4190/p A Wound R R R IR R R MDR
10 1959/o Bronchi R R R R R R R IR R R XDR
11 3109/o Urine R R R R R R R R R MDR
12 1286/o Urine, blood R R R R
13 55/K Bronchi R R R R R R R R R R R R R R XDR
14 978/K Pleura R R R R R R R R R R R XDR
15 K3 Blood R R R R R R R R MDR
16 K4 Blood R R R R R R R R R R R R R R R XDR
17 792/K Wound R R R R R R R IR MDR
18 393/K Urine R R R R IR
19 133/K Urine
20 23/K Urine R IR
21 887/K Wound R R R R R R R R R R R XDR
22 169/K Nose R R R R R R R R R R R R R IR XDR
23 3752/sz Ear R
24 4908/p Urine R R
25 3907/sz Uterus R R R R
26 15/p I Tracheostomy tube R
27 149/p Urine
28 153/s Urine R R
29 547/p Ear R
30 1885/K Bronchi R R R R R R R R R R R R R IR XDR
31 556/K Wound R R R R R R R R R R R IR XDR
32 1651/p Urine R
33 1304/s Urine R R ND R R MDR
34 1804/p Urine R IR
35 2284/p Ear R IR
36 143/p Wound R R

Antimicrobial susceptibility testing included following antimicrobials: PIP, piperacillin; TIM, ticarcillin-clavulanic acid; TZP, piperacillin-tazobactam; FEP, cefepime; CAZ, ceftazidime; IPM, imipenem; MEM, meropenem; DOR, doripenem; GEN, gentamicin; AMK, amikacin; NET, netilmicin; TOB, tobramycin; CIP, ciprofloxacin; LVX, levofloxacin; CST, colistin; PMB, polymyxin B; FOF, fosfomycin; AZT, aztreonam. R, resistant; IR, intermediate resistant, no letter – sensitive.